Second-line Oxaliplatin Benefits Pancreatic Cancer PatientsSecond-line Oxaliplatin Benefits Pancreatic Cancer Patients

Dr Alok Khorana reports on the CONKO study, which shows that patients with pancreatic cancer who receive gemcitabine in first-line therapy benefit from second-line oxaliplatin-based therapy. Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Viewpoint Source Type: news